Lumpectomy defects often need to be closed carefully to minimize scar contracture following radiation therapy. The reduction or mastopexy pattern actually facilitates radiation delivery as it produces a more compact target for a directed radiation beam. In general, radiation begins approximately 6 weeks after lumpectomy unless chemotherapy is to be initiated. It is important for all wounds to be healed…
The same patterns that are used to improve the appearance of the breast can also be utilized to remove cancers in the breast. We encourage our patients to consume approximately 80-100 grams of protein per day for 4-6 weeks prior to surgery and for 4-6 weeks after surgery. The protein intake is important to facilitate wound healing. In general the…
Standard breast lift patterns are used to reconstruct the breast following lumpectomy. Often the tumor will be outside of the confines of the aesthetic mastopexy patterns and the pattern is adjusted. Post-operatively, xeroform gauze and Bacitracin ointment are placed on the wound edges. The xeroform gauze is removed after two days, by the patient, in the shower. It is common…
Many patients with breast cancer either choose or have cancers that are amenable to successful treatment with lumpectomy and radiation. This tends to be performed in an outpatient setting. Patients are instructed to wear a sports bra for 6 weeks after surgery. A high protein diet is important to facilitate healing after IORT or to get the wounds healed in…
Breast cancer can be treated with lumpectomy or mastectomy, depending upon the size of the cancer, location, size of the breast, and genetic positivity for cancer syndromes. Oncoplastic reconstruction of lumpectomy defects involves reconstructing the patients breast with their own breast tissue. Typically the breasts are made smaller and placed into a better position. This improved position often facilitates radiation…
There are several inherited genetic mutations that may make a person more susceptible to breast cancer. Commonly encountered genetic mutations such as BRCA1, BRCA2, PALB2, and CHEK2 are identified in patient with breast cancer and those with DCIS. Frequently, these patients may wish to undergo contralateral prophylactic mastectomy. Prophylactic mastectomy is the removal of a normal breast to prevent the…
